Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2005

Effect of lower-body negative pressure on cerebral blood fl ow velocity during 21 days head-down tilt bed rest

Xi-Qing Sun, Yong-Jie Yao, Chang-Bin Yang, Shi-Zhong Jiang, Chang-Lin Jiang, Wen-Bin Liang

Med Sci Monit 2005; 11(1): CR1-5 :: ID: 13868

Abstract

Background: The purpose of this study was to investigate cerebral blood fl ow (CBF) velocity in humans during 21 days of head-down tilt (HDT) bed rest with and without lower-body negative pressure (LBNP). Material/Methods: Twelve healthy male volunteers were exposed to –6° HDT bed rest for 21 days. Six subjects received –30 mmHg LBNP sessions for 1 h per day from the 1[sup]st[/sup] to the 7[sup]th[/sup] day and from the 15[sup]th[/sup] to the 21st day of HDT, and six others served as controls. CBF velocity was measured by use of the transcranial Doppler technique in the right middle cerebral artery before and during HDT. Results: In the control group, mean and systolic CBF velocities decreased on day 1 of HDT compared with the pre-HDT value, and dropped further on day 3 of HDT, then remained signifi cantly below the pre-HDT baseline on days 7 and 10 of HDT, and reached a minimum value on day 21 of HDT. In the LBNP group, mean and systolic CBF velocities decreased signifi cantly on day 1 of HDT compared with the pre-HDT value, and remained lowered throughout HDT. Diastolic CBF showed no signifi cant change throughout HDT in both groups. There were no signifi cant differences in these parameters between the two groups. Conclusions: The results of this study suggest that CBF velocity is reduced during 21 days of HDT, and brief daily LBNP sessions used in the fi rst and last weeks of 21-day HDT bed rest does not improve CBF velocity.

Keywords: Head-Down Tilt - adverse effects, Bed Rest, Blood Pressure, Cerebrovascular Circulation, Head-Down Tilt - adverse effects, Lower Body Negative Pressure, Ultrasonography, Doppler, Transcranial, Weightlessness

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750